Literature DB >> 6214629

The value of quantitative radioisotope scanning in the differential diagnosis of low back pain and sacroiliac disease.

M L Snaith, S E Galvin, M D Short.   

Abstract

The specificity of scintigraphic scanning in detecting inflammatory sacroiliitis has been investigated. The sacroiliac band profile (R[Band]) was used and a new index (R[SIJ/F]) comparing the sacroiliac joint with the ipsilateral femur is described. Using the R (Band) index the mean value (1.34) for patients with definite sacroiliac disease was no different from that found for control subjects (1.35). There were significant differences using the R(SIJ/F) (7.8 versus 6.4): this ratio alone correlated with age. We conclude that neither technique is sufficiently specific to be of diagnostic value in most instances of low back pain.

Entities:  

Mesh:

Year:  1982        PMID: 6214629

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Quantitative sacroiliac scintiscanning: a sensitive and objective method for assessing efficacy of nonsteroidal, anti-inflammatory drugs in patients with sacroiliitis.

Authors:  N A Dunn; B H Mahida; M V Merrick; G Nuki
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

2.  Application of Bayes' theorem to the diagnosis of ankylosing spondylitis from radioisotope bone scans.

Authors:  B L Diffey; B Pal; C J Gibson; C B Clayton; I D Griffiths
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

Review 3.  Imaging of the seronegative spondyloarthropathies.

Authors:  A A Luong; D C Salonen
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 4.  Role of technetium-99m planar bone scanning in the evaluation of low back pain.

Authors:  D C Valdez; R G Johnson
Journal:  Skeletal Radiol       Date:  1994-02       Impact factor: 2.199

5.  The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis.

Authors:  S D Miron; M A Khan; E J Wiesen; I Kushner; E M Bellon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.